# UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia

> **NCT00003598** · NA · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 180 (estimated)

## Conditions studied

- Cervical Cancer
- Precancerous/Nonmalignant Condition

## Interventions

- **DRUG:** tretinoin

## Key facts

- **NCT ID:** NCT00003598
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01
- **Primary completion:** 2001-03
- **Final completion:** 2009-11
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2010-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003598, "UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*